Nuclear Medicine and Biology
Volume 36, Issue 4 , Pages 389-393, May 2009

Application of highly sensitive UPLC–MS to determine biodistribution at tracer doses: validation with the 5-HT1A ligand [18F]FPWAY

PET Radiochemistry Group, National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health, Bethesda, MD 20892, USA

Received 13 August 2008; received in revised form 12 December 2008; accepted 12 January 2009. published online 27 March 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0969-8051(09)00002-X

doi:10.1016/j.nucmedbio.2009.01.002

Nuclear Medicine and Biology
Volume 36, Issue 4 , Pages 389-393, May 2009